Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genmab
Eli Lilly and Company
Pfizer
Akeso
Seagen Inc.
Memorial Sloan Kettering Cancer Center
Enliven Therapeutics
City of Hope Medical Center
Akeso
Bristol-Myers Squibb
BeiGene
Memorial Sloan Kettering Cancer Center
Pfizer
Sun Yat-sen University
Toray Industries, Inc
DEKA Biosciences
Takeda
Vejle Hospital
National Cancer Institute (NCI)
Ono Pharmaceutical Co. Ltd
Academic and Community Cancer Research United